General Scientific Aspects of Personalised Medicine: The Healthcare Biotech Industry Perspective

On 19 March 2010, EuropaBio organised its first Workshop on personalised medicine entitled: General Scientific Aspects of Personalised Medicine: The Healthcare Biotech Industry Perspective. Attended by a large audience of policy-makers, regulators and industry experts, the workshop provided participants with an overview of the scientific aspects of personalised medicines including, among others, the role of genomics in the latest developments of personalised medical applications or the use of diagnostics in clinical development.

The presentations can be downloaded as follows:

For further information about this first workshop or follow-on events, please contact Ludovic Lacaine, Director, Healthcare Biotech.